Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin prophylaxis in cesarean delivery: maternal postoperative infections and early neonatal complications
IRCT201506084339N10Phase 3Completed
- Sponsor
- Bushehr University of Medical Sciences
- Start
- May 2015
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cefazolin in surgical site infection (SSI) and early neonatal complications, sponsored by Bushehr University of Medical Sciences. Primary endpoints: Maternal postoperative infections and Early neonatal complications. Started May 2015; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)early neonatal complications
Beyond the preview
Go deeper on IRCT201506084339N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201506084339N10.